GGrantIndex
← Search

REPURPOSING THYMOQUINONE AS THERAPY FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

$852,000FY2018Department of the ArmyDOD

The Morehouse School Of Medicine, Inc.

Investigators

View source on USAspending →
REPURPOSING THYMOQUINONE AS THERAPY FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER · GrantIndex